Ascendis Pharma A/S | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (23)

View All

Latest Posts

About This Stock More About This Stock
Week In Review: ProfoundBio, A Seattle-Suzhou ADC Biotech, Acquired By Genmab For $1.8 Billion
Article By: ChinaBio® Today
Saturday, April 6, 2024 1:20 PM EDT
ProfoundBio will be acquired by Copenhagen’s Genmab A/S in a $1.8 billion all-cash deal. The acquisition will expand Genmab’s drug portfolio, including three ProfoundBio clinical stage ADC candidates for solid tumors.
In this article: INCY, GMAB, CHSYF, BMY, HCM, ZLAB, IVBXF Also: ASND
Read
Dow Up Triple Digits As Second Quarter Kicks Off
Article By: Schaeffers Research
Monday, April 3, 2023 12:28 PM EDT
The Dow Jones Industrial Average is up 146 points midday to kick off the second quarter, while the S&P 500 Index inches lower, and the Nasdaq Composite sits firmly in the red.
In this article: SLB, QQQ, HSKA, SPX, VIX, DJI, ASND
Read
Week In Review: Qitan Raises $101 Million For Nanopore Sequencing Devices
Article By: ChinaBio® Today
Saturday, January 14, 2023 2:20 PM EDT
Qitan Technology, a Chengdu nanopore sequencing company, completed a $101 million Series C round to support its commercialized nanopore devices. Meanwhile, Japan’s Takeda was approved to launch Exkivity in China.
In this article: TAK Also: AZN, LLY, ASND
Read
The Week Ahead In Biotech (Oct. 3-9): ChemoCentryx FDA Decision, Conference Presentations, IPOs, And More
Article By: Benzinga
Sunday, October 3, 2021 3:45 PM EDT
Biotech stocks came under pressure in the week ending Oct. 1, dragged by broader market weakness and the selling of vaccine stocks. Here are the key catalysts that could move stocks in the unfolding week.
In this article: MRK, CCXI, TPTX, XLRN, ASND, TAK, BCYC, RLAY, PRLD, RPTX
Read
The Week Ahead In Biotech (Aug. 29- Sept. 4): Merck's Keytruda Regulatory Decision, Stray Earnings On Tap In A Light Week
Article By: Benzinga
Sunday, August 29, 2021 4:30 PM EDT
Biopharma stocks had a strong start to the week amid optimism generated by full approval accorded to the mRNA vaccine developed by Pfizer, Inc. and BioNTech SE. The stocks subsequently moved back and forth in a narrow range before ending higher.
In this article: MRK, PFE, ESALY, ASND, BTCY, SAVA, BNTX, INMB, RNXT, CO
Read
All Posts

Latest Tweets for $ASND

No tweets yet!

PARTNER HEADLINES